Although the rats in the silenced IGF2R-MSCs group showed an aggravated the progression of HCC which compared to PBS group, they exhibited alleviation in the liver injury, tumor burden and the number of dysplastic nodules compared to the MSCs group (Fig. 5L-N). Here, IGF2R is linked to hepatocellular carcinoma.